Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,174.61
-1.4900-0.13%
Volume:2.45M
Turnover:2.87B
Market Cap:1.11T
PE:39.43
High:1,180.00
Open:1,172.66
Low:1,162.93
Close:1,176.10
52wk High:1,292.65
52wk Low:712.05
Shares:945.38M
Float Shares:939.00M
Volume Ratio:1.02
T/O Rate:0.26%
Dividend:6.69
Dividend Rate:0.57%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:32.78
PE(LYR):51.18

Loading ...

UK Green Lights Lilly's Obesity Pill

Reuters
·
Aug 10

UK’s MHRA Authorises Orforglipron for Weight Management and Type 2 Diabetes

Reuters
·
Aug 10

Analysts Conflicted on These Healthcare Names: Evolent Health (EVH), Eli Lilly & Co (LLY) and BioMarin Pharmaceutical (BMRN)

TIPRANKS
·
Aug 10

Nvidia, Eli Lilly, and Disney Show It's Time to Back the Top Dogs

Dow Jones
·
Aug 10

Eli Lilly and Company Just Beat Revenue By 11%: Here's What Analysts Think Will Happen Next

Simply Wall St.
·
Aug 08

Form 144 | ELI LILLY Officer Hakim proposes to sell 10000 Shares, with a total value of approximately $11.9 Million.

Filings Track
·
Aug 07

Mediar Therapeutics Signs Collaboration, Option Deal with Ono Pharma on Fibro-Inflammatory Disease Antibodies

Reuters
·
Aug 07

Eli Lilly : Truist Securities Raises Target Price to $1376 from $1370

THOMSON REUTERS
·
Aug 07

Morning BID Americas-Dealjà Vu

Reuters
·
Aug 07

Truist Adjusts Price Target on Eli Lilly & Co. to $1,376 From $1,370, Maintains Buy Rating

MT Newswires Live
·
Aug 07

8 ‘trendsetter’ stocks for world’s top mega-trends: Jon Erlichman

Bloomberg
·
Aug 07

Eli Lilly's Incretin Performance Supports Long-Term Growth, Truist Says

MT Newswires Live
·
Aug 07

The Race to Come up with the Next Big Sleep Drug

Dow Jones
·
Aug 07

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Eli Lilly & Co (LLY), Exelixis (EXEL) and Moderna (MRNA)

TIPRANKS
·
Aug 06

Eli Lilly Outperformance and Incretin Momentum Support Buy Rating with Unchanged $1,385 Price Target

TIPRANKS
·
Aug 06

Rumors Swirl That Eli Lilly (LLY) Will Split Its Stock After Blockbuster Earnings

TIPRANKS
·
Aug 06

Movement Alert|Eli Lilly Rises 3.94% in Regular Trading, Multiple Wall Street Firms Raise Price Targets After Blowout Q2 Earnings

Market Focus
·
Aug 06

Stock Track | Eli Lilly Soars 5% Intraday as Strong Q2 Earnings and Analyst Upgrades Fuel Rally

Stock Track
·
Aug 06

Eli Lilly is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Aug 06

Scotiabank Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

TIPRANKS
·
Aug 06